Status:
COMPLETED
Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic Imaging
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Beckman Laser Institute University of California Irvine
Conditions:
Sarcoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the ability of a specific imaging method, termed Diffuse Optical Spectroscopic Imaging, to provide metabolic and functional information which can be used to p...
Detailed Description
In this study we plan to measure bone and soft tissue sarcoma patients using Diffuse Optical Spectroscopic Imaging to determine if analogous markers of response exist for these patients. The first aim...
Eligibility Criteria
Inclusion
- Any subjects with no current or previous history of sarcoma are eligible to be a normal volunteer
- Any subject with a sarcoma neoplasm is eligible to be measured for aim 2 of the study
- Only patients undergoing neoadjuvant chemotherapy for sarcoma are eligible for Aim 3 of the study
Exclusion
- Age less that 18 year old
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01263405
Start Date
December 1 2010
End Date
October 1 2014
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beckman Laser Institute
Irvine, California, United States, 92612